Anesthesiologist Company

Leen Kawas: A Leader in Biotechnology

Leen Kawas is a prominent biotech executive and entrepreneur, known for her innovative work in developing new treatments for neurological disorders. She is currently the CEO of M3 Biotechnology, a clinical-stage biotech company focused on developing drugs to treat Alzheimer’s disease and other neurodegenerative disorders.

Leen Kawas has a strong background in biotech and pharmaceuticals, with a PhD in pharmacy and pharmaceutical sciences from the University of Jordan, and a postdoctoral fellowship in neurology and neuroscience from the University of California, Irvine. She also holds an MBA from Seattle University, which has helped her develop the business acumen needed to lead successful biotech companies.

Before joining M3 Biotechnology, Kawas served as the CEO of Athira Pharma, where she was instrumental in developing novel treatments for Alzheimer’s disease. She also held senior leadership positions at Amgen, one of the largest biotech companies in the world, where she worked on the development of several innovative drugs.

Throughout her career, Kawas has been a strong advocate for women in STEM fields and has worked to promote diversity and inclusivity in the biotech industry. She has been recognized for her leadership and entrepreneurship by several organizations, including being named one of Puget Sound Business Journal’s 40 under 40 honorees in 2019.

Kawas is also committed to giving back to her community. She is a board member of the Seattle Foundation, a nonprofit organization that supports community-based philanthropy in the Seattle area. She is also a member of the Leadership Council of the Alzheimer’s Association, which works to advance research and improve care for those affected by Alzheimer’s disease.

In conclusion, Leen Kawas is a respected leader in the biotech industry, known for her innovative work in developing new treatments for neurological disorders. Her strong background in both science and business has made her a valuable asset to the companies she has worked for, and her commitment to promoting diversity and inclusivity in the industry is an inspiration to others. Through her work and philanthropy, Kawas has made a significant impact on the biotech industry and her community.